FAIM2 and neuroblastoma: In conclusion, we here provide a validated 20-plex MELC panel for neuroblastoma composed of DTC markers, including a novel candidate marker called FAIM2, as well as myeloid, lymphoid, mesenchymal, and hematopoietic stem and progenitor cell markers (Figure 1f).